Literature DB >> 17944003

Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapy.

Min Ye1, Shwu-Huey Liu, Zaoli Jiang, Yashang Lee, Robert Tilton, Yung-Chi Cheng.   

Abstract

PHY906 is a Chinese medicine formulation prepared from four medicinal herbs for adjuvant cancer chemotherapy. In this paper, liquid chromatography/electrospray ionization time-of-flight mass spectrometry (LC/ESI-TOFMS) was used to clarify the chemical composition of PHY906. The aqueous extract of PHY906 was separated on a Waters Atlantis C(18) column, and was eluted with acetonitrile/0.05% (v/v) formic acid. The separated compounds were identified with pure standards, or tentatively characterized by analyzing their mass spectra recorded in both negative and positive ion polarity modes. Further structural information was obtained from in-source fragmentation. Based on the LC/MS analysis, we proposed the structures for 64 bioactive compounds, including flavonoids, triterpene saponins, and monoterpene glycosides. All the compounds identified from PHY906 were further assigned in the four individual herbs, and some of them are reported for the first time. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944003     DOI: 10.1002/rcm.2832

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  21 in total

Review 1.  Cancer Biomarkers for Integrative Oncology.

Authors:  Aniruddha Ganguly; David Frank; Nagi Kumar; Yung-Chi Cheng; Edward Chu
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

2.  Cancer complementary and alternative medicine research at the US National Cancer Institute.

Authors:  Libin Jia
Journal:  Chin J Integr Med       Date:  2012-01-12       Impact factor: 1.978

3.  Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.

Authors:  Shuaizhen Zhou; Pierre-Marie Allard; Christian Wolfrum; Changqiang Ke; Chunping Tang; Yang Ye; Jean-Luc Wolfender
Journal:  Metabolomics       Date:  2019-07-18       Impact factor: 4.290

Review 4.  Safety surveillance of traditional Chinese medicine: current and future.

Authors:  Shwu-Huey Liu; Wu-Chang Chuang; Wing Lam; Zaoli Jiang; Yung-Chi Cheng
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

5.  A brief report: Yale Research Symposium on Complementary and Integrative Medicine.

Authors:  Ather Ali; Lawrence A Vitulano
Journal:  Yale J Biol Med       Date:  2010-09

6.  A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906.

Authors:  Robert Tilton; Anthony A Paiva; Jing-Qu Guan; Rajendra Marathe; Zaoli Jiang; Winfried van Eyndhoven; Jeffrey Bjoraker; Zachary Prusoff; Hailong Wang; Shwu-Huey Liu; Yung-Chi Cheng
Journal:  Chin Med       Date:  2010-08-20       Impact factor: 5.455

7.  Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.

Authors:  Sara Rockwell; Tina A Grove; Yanfeng Liu; Yung-Chi Cheng; Susan A Higgins; Carmen J Booth
Journal:  Int J Radiat Biol       Date:  2012-09-03       Impact factor: 2.694

Review 8.  Untargeted metabolomics: an emerging approach to determine the composition of herbal products.

Authors:  Mauro Commisso; Pamela Strazzer; Ketti Toffali; Matteo Stocchero; Flavia Guzzo
Journal:  Comput Struct Biotechnol J       Date:  2013-02-28       Impact factor: 7.271

9.  YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment.

Authors:  Xiaochen Yang; Wing Lam; Zaoli Jiang; Fulan Guan; Xue Han; Rong Hu; Wei Cai; William Cheng; Shwu-Huey Liu; Peikwen Cheng; Yuping Cai; Nicholas J W Rattray; Caroline H Johnson; Lieping Chen; Yung-Chi Cheng
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  The four-herb Chinese medicine ANBP enhances wound healing and inhibits scar formation via bidirectional regulation of transformation growth factor pathway.

Authors:  Qian Hou; Wen-Jun He; Hao-Jie Hao; Qing-Wang Han; Li Chen; Liang Dong; Jie-Jie Liu; Xiang Li; Ya-Jing Zhang; Ying-Zhi Ma; Wei-Dong Han; Xiao-Bing Fu
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.